Knome's Co-founder Jorge Conde has joined Syros Pharmaceuticals as CFO and chief product officer where he will lead the platform strategy for Syros' novel gene regulation technology and manage the overall finances for the company. Conde most recently served as Knome's CFO, but has also worked in marketing and operations at MedImmune, as well as at Helicos Biosciences. Previously, he was an investment banker at Morgan Stanley.
Myriad's CFO James Evans has retired, but will continue to serve as CFO until the company finds a replacement. He joined Myriad in 1995 as a corporate controller and was promoted to vice president of finance in 2005. In 2007, he was named CFO.